Concepedia

Zhaoyang Meng

ZM

18

Publications

608

Citations

13

H-Index

1997

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Beijing Friendship Hospital

Capital Medical University

Kettering University

Columbia University

Zhaoyang Meng is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1997–2024

18

Publications

18

The lncRNA TUG1/miR-145-5p/FGF10 regulates proliferation and migration in VSMCs of hypertension

Lin Shi, Caijun Tian, Lingzhi Sun et al. · Biochemical and Biophysical Research Communications · 2018 · 112 citations

, , +9

TGF-β participates choroid neovascularization through Smad2/3-VEGF/TNF-α signaling in mice with Laser-induced wet age-related macular degeneration

Xiaolei Wang, Song Han, Zhaoyang Meng et al. · Scientific Reports · 2017 · 78 citations · Full text

A Synthetic Pathway to Either Enantiomer of Merrilactone A

Zhaoyang Meng, Samuel J. Danishefsky · Angewandte Chemie International Edition · 2005 · 64 citations

, , +14

A Novel Class of Endotoxin Receptor Agonists with Simplified Structure, Toll-Like Receptor 4-Dependent Immunostimulatory Action, and Adjuvant Activity

Lynn D. Hawkins, Sally T. Ishizaka, Pamela D. McGuinness et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 62 citations

Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors

David Belanger, Patrick J. Curran, Alan Hruza et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 40 citations · Full text

, , +3

Rows per page

1–5 of 18